Name

astma-allergi danmark

Legal name

Astma-Allergi Danmark

Website

https://astma-allergi.dk

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Allergy and Asthma Patient Advocacy Services

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Asthma & Allergy-Related Pulmonary Care (HLAKANAD)

Keywords

• Allergy patient advocacy
• Pollen forecasting services
• Allergy certification labeling
• Asthma health advisory
• Patient membership services

Headquarters

HQ city

Roskilde

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Fees: Astma-Allergi Danmark generates revenue through membership subscriptions. The organization helps approximately 1.5 million Danes affected by asthma, allergy, or hypersensitivity diseases.
2. Donations and Legacies: The organization receives donations and bequests from supporters.
3. Industry Partnerships and Project Sponsorships: Astma-Allergi Danmark enters into collaboration agreements with pharmaceutical and medical device companies for specific projects. Collaborations follow Danish Patient Associations' guidelines. Notable partners include Scandinavian Biopharma (Nutramigen), Novartis Healthcare A/S, and ALK-Abelló Nordic A/S.
4. Newsletter and Email Communications: The organization uses Mailchimp as a data processor for sending newsletters and member communications. Electronic mailings include news and information relevant to members.
5. Advertising Revenue: Advertising is sold in the member magazine AstmaAllergi, pollenmail, newsletter, and the Dagens Pollental app through FrontMedia.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Astma-Allergi Danmark is a Danish nonprofit patient association serving approximately 1.5 million Danes affected by asthma, allergy, or other hypersensitivity diseases. The organization provides pollen counting and forecasting, allergy certification labeling (Asthma Allergy Nordic), advisory services, educational content, and membership-based services to support individuals living with allergic and respiratory conditions.

Product overview

Astma-Allergi Danmark operates as a patient association providing a comprehensive suite of products and services centered on pollen monitoring, allergy management, and patient education. The core offering consists of Dagens Pollental (daily pollen count service) and the Dagens Pollental App, which together deliver real-time pollen data and symptom tracking. Supporting these are digital tools including Pollenportalen (educational content), Pollenmail (email alerts), Pollenkalenderen (calendar), and Pollengrafer (trend visualization). The organization also offers AllergiLex (ingredient checker) and the Asthma Allergy Nordic certification program for approved products. Additional services include advisory/consultation services, the Astma+Allergi member magazine, and the Luftrummet podcast. The ecosystem is designed to serve the approximately 1.5 million Danes affected by asthma and allergies.

Differentiator

Problem solved

Functional benefit

Brands

• Asthma Allergy Nordic: The allergy certification labeling program operated by Astma-Allergi Danmark, formerly known as Den Blå Krans.
• Pollenportalen
• Dagens Pollental

Products and services

• Asthma Allergy Nordic Certification An allergy and asthma-friendly certification label program that helps consumers identify products suitable for people with allergies, asthma, or hypersensitivity. The certification is awarded to products meeting specific allergy-friendly standards.
• Pollen Counting and Forecasting Service A service providing daily pollen counts and forecasts to help individuals with pollen allergies manage their symptoms and plan daily activities. The service tracks pollen levels across Denmark.
• Patient Advisory Services Advisory services providing guidance and support to individuals affected by asthma, allergy, or hypersensitivity diseases. Services include health information, condition management advice, and patient support.
• Membership Program A membership-based service offering access to exclusive content, advisory support, and benefits for individuals affected by asthma, allergy, or hypersensitivity diseases. Members gain access to the organization's resources and community support.
• Educational Content and Resources Educational materials, articles, guides, and resources about asthma, allergy, and hypersensitivity diseases. Content helps patients, families, and the broader public understand and manage allergic conditions.

Quantifiable outcome

• 450,000+ users of the Dagens Pollental app, helping Danes manage pollen exposure during allergy season.
• +6 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature4 records

Partnerships

Six partnerships are on record, tiered minor.

• ALK-Abelló Nordic A/SminorStrategic or Co-development Partner · 1 January 2026Two collaborations with ALK-Abelló Nordic A/S: (1) Patient-oriented hay fever courses and webinars with special focus on pollen allergy in 2026. Budget: 241,000 DKK. (2) A round table discussion about allergy for important stakeholders. Budget: 220,000 DKK. Purpose is to teach citizens and their relatives about hay fever with special focus on pollen allergy and allergic asthma, and to strengthen focus on allergy diagnosis and treatment in the healthcare system.
• Novartis Healthcare A/SminorStrategic or Co-development Partner · 1 January 2025Collaboration with Novartis Healthcare A/S for hosting courses about urticaria for people with urticaria. Purpose is to give patients with urticaria and their relatives knowledge about the disease, treatment options, and practical daily life advice. The new knowledge should strengthen disease control, increase quality of life, and reduce limitations in daily life. Duration: 2025/2026. Budget: 207,000 DKK.
• Scandinavian Biopharma (Nutramigen)minorStrategic or Co-development Partner · 1 January 2024Collaboration with Scandinavian Biopharma (Nutramigen) for a course program for a network of health visitors, delivering two courses. Purpose is to disseminate knowledge about allergy to the country's health visitors. Project type: Sponsorship. Duration: 2024/2025. Budget: 98,500 DKK.
• FrontMediaminorChannel Partner/ Reseller/ DistributorFrontMedia handles advertising sales for Astma-Allergi Danmark's media platforms, including the member magazine AstmaAllergi, pollenmail, newsletter, and the Dagens Pollental app. Contact: Gammel Strandvej 16, 2990 Nivå, Tlf.: 4822 4450.
• Videncenter for Allergi (Knowledge Center for Allergy)minorStrategic or Co-development PartnerVidencenter for Allergi conducts research referenced by Astma-Allergi Danmark, including patch test series development and nickel/nickel regulation research. The organization works closely with the Knowledge Center for Allergy on allergy diagnostics and prevention.
• Danske Patienter (Danish Patients)minorOthersAstma-Allergi Danmark follows Danske Patienters guidelines for collaboration with the pharmaceutical and medical device industry. The organization's collaboration agreements with pharmaceutical companies follow these guidelines.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Pollen.com: US consumer-facing pollen forecast and allergy information service. Comparable as a digital pollen/allergy platform providing location-based pollen counts, forecasts and allergy content to a mass consumer audience.
• Astma- och Allergiförbundet: Swedish national patient association for asthma and allergy. Directly comparable as a Nordic member-based patient organization offering allergy information, advisory services, and product certification in an adjacent single-country market.
• Asthma and Allergy Foundation of America (AAFA): Leading US patient organization for asthma and allergy. Directly comparable in mission: patient advocacy, education, research funding, and certification-style programs (e.g., asthma & allergy friendly certification) for a national consumer base.
• Allergy UK: UK national charity for people with allergy. Directly comparable as a membership-style allergy patient organization offering advisory services, certification/endorsement schemes, and consumer-facing allergy information.
• Allergy & Asthma Network: US-based patient organization focused on asthma and allergies. Comparable in offering patient education, advocacy, and healthcare-professional outreach at a national level, with similar membership and partnership-driven funding.
• Asthma + Lung UK: Major UK charity for asthma and lung disease. Comparable as a member-supported nonprofit providing advice, research funding, campaigning, and digital content to a large national patient population with asthma and respiratory allergy.
• Norges Astma- og Allergiforbund (NAAF): Norwegian patient association for asthma and allergy. Closely comparable mission and structure: member-supported nonprofit delivering advice, advocacy and information to people with asthma, allergy and hypersensitivity in a single Nordic country.

Emerging players

• ECARF (European Centre for Allergy Research Foundation): European allergy research and certification organization that awards the ECARF 'quality seal' for allergy-friendly products and services. Comparable to Astma-Allergi Danmark's Asthma Allergy Nordic certification line of business.

Broad incumbents

• AccuWeather: Large commercial weather data provider that has expanded into pollen forecasting and allergy content. Comparable as an emerging competitor/aggregator of pollen data that threatens standalone allergy app destinations.
• European Federation of Allergy and Airways Diseases Patients' Associations (EFA): European umbrella federation of national allergy and respiratory patient associations, including Astma-Allergi Danmark's Nordic counterparts. Comparable as a higher-level patient advocacy body operating across multiple EU countries.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/AstmaAllergiDK
• Facebookfacebook.com/AstmaAllergiDanmark
• LinkedInlinkedin.com/company/astma-allergi-danmark
• Instagraminstagram.com/astmaallergidk

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about astma-allergi danmark